Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Biomerica develops diagnostic products for screening and detection of chronic medical conditions and cancers, offered as at-home tests, point-of-care solutions, and laboratory assays for healthcare providers and consumers.
0 investors
0 investors
Bionano develops optical genome mapping (OGM) systems and analysis software that detect structural variants and chromosomal aberrations across the genome. Its tools serve clinical care, research, and therapeutics applications including hematological malignancies, solid tumors, reproductive health, rare disease, and cell line quality control.
0 investors
0 investors
0 investors
Biophoundry develops phage-based technologies for therapeutics, diagnostics, and bio-molecular engineering, including its Phax platform aimed at making phage therapy faster and more affordable. The company focuses on precision antibiotics to address antimicrobial resistance, combining synthetic biology, robotics, and data science.
0 investors
0 investors
BioPoly develops biomaterial implants made from a proprietary self-lubricating material combining hyaluronic acid and polyethylene for orthopedic applications, enabling partial joint resurfacing and cartilage replacement. The company serves orthopedic surgeons and patients seeking less invasive joint repair solutions, with products approved in Europe and the U.S.
0 investors
BioQ Pharma is a pharmaceutical company with expertise in biotech development and healthcare technology. The company appears to be focused on pharmaceutical innovation with a board of directors drawn from senior executives with extensive experience in biotech, medical devices, and pharma commercialization.
0 investors
BioRegenx develops hardware and software for microscopy imaging of the endothelial glycocalyx, along with microvascular regenerative products, serving doctors, research scientists, and wellness consumers. The company combines diagnostic imaging technology with regenerative therapeutics in the medical device and wellness sector.
0 investors
BioRestorative Therapies develops cell- and tissue-based therapeutic products, primarily using adult stem cells, targeting conditions such as degenerative disc disease and metabolic disorders. It also runs a BioCosmeceutical platform applying secretome-based biologics to aesthetic medicine, and is a publicly traded company (NASDAQ:BRTX).
0 investors
0 investors
0 investors
0 investors
0 investors
Streamex Corp. operates a blockchain-based platform for tokenizing real-world assets, beginning with GLDY, a digital token backed by physical gold held in a Cayman Islands special purpose vehicle with yield generated through gold leasing; the company also maintains a legacy medical device business developing advanced signal processing software for cardiac electrophysiology applications.
0 investors
0 investors
0 investors
BioStem Technologies develops human amniotic membrane allograft products for advanced surgical care and wound care, used as adjunct treatments for chronic and acute wounds. Its offerings use cryopreserved, hydrated, and dehydrated membrane technologies for clinical and veteran patient populations.
0 investors
0 investors
BioSurfaces develops medical devices, 3D tissue engineering scaffolds, and personal care products using its proprietary Bio-Spun nanofiber technology. The company works in the medical device and tissue engineering space, with collaborations that include Takeda, NIH, and Corning.
0 investors
0 investors